Product Details

Vercef Dry Syrup meets pharmacopoeial standards for the treatment of bacterial infections in children. Specifically, each 5ml of reconstituted suspension delivers Cefixime IP (as Trihydrate) at 100mg. As a result, it offers broad-spectrum, third-generation cephalosporin coverage in a convenient, flavoured liquid formulation suited to paediatric use.

The syrup contains:

• Cefixime IP (as Trihydrate, 100mg per 5ml, in a flavoured base) – A third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Consequently, it exerts bactericidal activity against a broad range of gram-positive and gram-negative organisms, including many resistant to earlier-generation antibiotics.

Physicians prescribe Vercef Dry Syrup for the treatment of susceptible bacterial infections in children, including respiratory tract infections, urinary tract infections, and ear, nose, and throat infections. In addition, its dry syrup format, reconstituted before use, along with the flavoured base, supports easier administration and better acceptance in young patients. Because of this profile, Vercef Dry Syrup suits paediatric practices, general practice, and hospital settings treating bacterial infections in children.

Key Features:

• Overall, this formulation guarantees pharmaceutical-grade purity
• Additionally, the dry syrup format supports accurate reconstitution and easy paediatric dosing
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 100mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, the flavoured base improves palatability and supports better patient compliance
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies